Xtract One Technologies Inc. has seen notable price action this week amid significant developments in its business operations.
This week, Xtract One Technologies Inc. (XTRA.TO) experienced a decline in its stock price, closing down 1.75% on the day and 5.08% over the past week. The company's recent expansion into pharmaceutical and life sciences manufacturing is a significant development that may influence investor sentiment.
Investor takeaway: Investors should consider the implications of Xtract One's recent expansion into new markets, as well as the stock's technical indicators and performance metrics, before making any decisions.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Xtract One Technologies Inc.
XTRA.TO
XTRA.TO
Xtract One Technologies Inc.
WealthAwesomeMarket cap
$145.56M
52W high
$0.98
52W low
$0.34
1W change
-5.08%
Beta
1.39
Analyst Price Targets
Based on analyst covering XTRA
Wall Street analysts forecast XTRA stock price to rise 114.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.20
+114.3% Upside
Current Price
C$0.56
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on XTRA's historical volatility
30-Day Vol
90.5%
Annualized
90-Day Vol
71.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.67
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.59 | C$0.43 โ C$0.81 |
| 60 trading days | C$0.63 | C$0.41 โ C$0.98 |
| 90 trading days | C$0.67 | C$0.39 โ C$1.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Stock Down 20% Year-to-Date
Xtract One Technologies has struggled in 2023, with a year-to-date decline of 20%, reflecting ongoing challenges in the market.
Bull case
The company's expansion into pharmaceutical and life sciences manufacturing could open new revenue streams and strengthen its market presence. This growth may attract long-term investor interest.
Bear case
Despite its growth initiatives, Xtract One's negative profit margin and declining stock performance this year may raise concerns about the company's financial stability.
Recent Price Action
Xtract One Technologies Inc. has faced a challenging week, with its share price closing at C$0.56, reflecting a decline of 1.75% on Friday and a total decrease of 5.08% over the past week. This downward trend continues a year-to-date decline of 20%. The latest trading volume was 44,543 shares, significantly lower than the 20-day average volume of 140,404 shares, indicating reduced investor activity.
Company News and Developments
On July 14, 2026, Xtract One Technologies announced its further expansion into the pharmaceutical and life sciences manufacturing sectors with a new multi-state deployment. This strategic move may serve as a catalyst for future growth, potentially increasing the company's market share and revenue streams. Investors will be keen to see how this expansion impacts overall performance in the coming quarters.
Technical Picture
From a technical standpoint, Xtract One's stock is currently trading near its 50-day moving average of C$0.55, which is slightly above the current price by 0.9%. However, it is below the 200-day moving average of C$0.58 by 3.6%. The stock's 52-week range has been C$0.34 to C$0.98, indicating it is currently trading at 35% of that range. With a beta of 1.39, Xtract One's stock is more volatile than the broader market, suggesting that it may experience larger price swings.
Advertisement
